Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › DHODH inhibitor for use in treating hematologic cancers

DHODH inhibitor for use in treating hematologic cancers

US Patent 11458126 · Granted Oct 4, 2022

Estimated economic value: $40,412,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating pancreatic cancer2024
Method for treating pancreatic cancer2024
Compounds for treating spinal muscular atrophy2023
Compounds for treating spinal muscular atrophy2023
Substituted reverse pyrimidine Bmi-1 inhibitors2021
Compounds for treating spinal muscular atrophy2021
Compounds for treating spinal muscular atrophy2020
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid2020
Compounds for treating spinal muscular atrophy2019
Compounds for treating spinal muscular atrophy2019
Substituted reverse pyrimidine Bmi-1 inhibitors2019
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid2019